Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)
Bangladesh · Delayed Price · Currency is BDT 763.50
-12.00 (-1.55%)
At close: Jun 15, 2026
Ambee Pharmaceuticals Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | 5.53 | 5.31 | 9.68 | 9.09 | 8.06 | -13.01 |
Depreciation & Amortization | 4.64 | 5.51 | 6.05 | 7.54 | 6.05 | 6.92 |
Other Operating Activities | 25.7 | 0 | -0 | -37.09 | -0.09 | -0.32 |
Change in Accounts Receivable | -40.02 | -14.19 | -45.63 | -23.43 | -20.28 | -23.08 |
Change in Inventory | -26.49 | 11.11 | -24.67 | -18.36 | -50 | 31.37 |
Change in Accounts Payable | 0.54 | 0.54 | 0.61 | -1.57 | -0.67 | -2.84 |
Change in Income Taxes | -7.84 | -7.27 | -9.71 | 22.13 | -2.75 | 1.05 |
Change in Other Net Operating Assets | 19.53 | 20.72 | -2.26 | 6.46 | -13.51 | -5.54 |
Operating Cash Flow | -18.41 | 21.73 | -65.92 | -35.23 | -73.18 | -5.45 |
Capital Expenditures | 0 | -23.79 | -2.2 | -0.11 | -1.53 | - |
Investment in Securities | -15.66 | -152.6 | - | - | - | - |
Other Investing Activities | 0.06 | 0.06 | - | - | - | - |
Investing Cash Flow | -15.6 | -176.34 | -2.2 | -0.11 | -1.53 | - |
Short-Term Debt Issued | - | 161.94 | 81.82 | 101.48 | 132.69 | 10.62 |
Long-Term Debt Issued | - | - | 0.71 | - | - | - |
Total Debt Issued | 36.61 | 161.94 | 82.53 | 101.48 | 132.69 | 10.62 |
Short-Term Debt Repaid | - | - | -11.48 | -52.54 | -51.56 | - |
Long-Term Debt Repaid | - | -0.4 | - | -0.96 | -3.09 | -0.87 |
Total Debt Repaid | -0.33 | -0.4 | -11.48 | -53.5 | -54.65 | -0.87 |
Net Debt Issued (Repaid) | 36.28 | 161.54 | 71.05 | 47.98 | 78.04 | 9.76 |
Common Dividends Paid | -2.18 | -2.35 | -3.38 | -1 | -1.5 | -0.33 |
Other Financing Activities | -4.12 | -4.62 | 4.62 | - | - | - |
Financing Cash Flow | 29.98 | 154.56 | 72.3 | 46.98 | 76.54 | 9.43 |
Miscellaneous Cash Flow Adjustments | -0.06 | -0.06 | - | 0 | - | - |
Net Cash Flow | -4.09 | -0.1 | 4.17 | 11.64 | 1.83 | 3.98 |
Free Cash Flow | -18.41 | -2.06 | -68.12 | -35.34 | -74.71 | -5.45 |
Free Cash Flow Margin | -11.68% | -0.89% | -31.06% | -17.84% | -41.28% | -5.51% |
Free Cash Flow Per Share | -7.67 | -0.86 | -28.39 | -14.72 | -31.13 | -2.27 |
Cash Interest Paid | 0.34 | 0.39 | 1.93 | 3.69 | 5.77 | 5.82 |
Cash Income Tax Paid | 5.41 | 5.5 | 14.49 | 15.47 | 5.85 | -31.12 |
Levered Free Cash Flow | -24.87 | -483.28 | 400.07 | 1.12 | -104.8 | -2.47 |
Unlevered Free Cash Flow | -24.85 | -483.22 | 400.43 | 2.68 | -101.91 | 0.65 |
Change in Working Capital | -54.27 | 10.91 | -81.65 | -14.77 | -87.21 | 0.96 |